In this review:
The ATLANTIC can be rough
To thrombolyse or not to thrombolyse?
Another negative trial for darapladib in ACS
All in the best possible TASTE
Exploring type 2 AMI
Coffee drinkers rejoice
A PARADIGM shift for HF?
SIGNIFY results disappoint
FOCUS on adherence in secondary prevention
High-risk patients and the inverse care law
FAME 2 analysis
An ODYSSEY to reduce LDL cholesterol
Please login below to download this issue (PDF)